Authors:
URIUDA Y
WANG QD
HATORI N
NORDLANDER R
SJOQUIST PO
MATTSSON C
RYDEN L
Citation: Y. Uriuda et al., CORONARY THROMBOSIS THROMBOLYSIS IN PIGS - EFFECTS OF HEPARIN, ASA, AND THE THROMBIN INHIBITOR INOGATRAN/, Journal of pharmacological and toxicological methods, 39(2), 1998, pp. 81-89
Authors:
SHIMIZU M
WANG QD
SJOQUIST PO
NORDLANDER R
RYDEN L
Citation: M. Shimizu et al., MYOCARDIOPROTECTIVE EFFECTS OF FELODIPINE IN AN ANTIHYPERTENSIVE DOSAGE - AN EXPERIMENTAL-STUDY IN PIGS, Cardiovascular drugs and therapy, 12(1), 1998, pp. 37-45
Citation: M. Shimizu et al., THE LIPID-PEROXIDATION INHIBITOR INDENOINDOLE H290 51 PROTECTS MYOCARDIUM AT RISK OF INJURY-INDUCED BY ISCHEMIA-REPERFUSION/, Free radical biology & medicine, 24(5), 1998, pp. 726-731
Authors:
MOOR E
SILVEIRA A
VANTHOOFT F
TORNVALL P
BLOMBACK M
WIMAN B
RYDEN L
HAMSTEN A
Citation: E. Moor et al., COAGULATION-FACTOR-V (ARG(506)-]GLN) MUTATION AND EARLY SAPHENOUS-VEIN GRAFT OCCLUSION AFTER CORONARY-ARTERY BYPASS-GRAFTING, Thrombosis and haemostasis, 80(2), 1998, pp. 220-224
Citation: K. Malmberg et al., CALCIUM-ANTAGONISTS, APPROPRIATE THERAPY FOR DIABETIC-PATIENTS WITH HYPERTENSION, European heart journal, 19(9), 1998, pp. 1269-1272
Authors:
LINDE CL
BOCRAY A
JONSSON H
ROSENQVIST N
RADEGRAN K
RYDEN L
Citation: Cl. Linde et al., RE-USED PACEMAKERS - AS SAFE AS NEW - A RETROSPECTIVE CASE-CONTROL STUDY (VOL 19, PG 154, 1998), European heart journal, 19(3), 1998, pp. 527-527
Citation: L. Ryden, REUSE OF DEVICES IN CARDIOLOGY - PROCEEDINGS FROM A POLICY CONFERENCEAT THE EUROPEAN HEART HOUSE, 5-6 FEBRUARY, 1998, European heart journal, 19(11), 1998, pp. 1628-1631
Authors:
ORTHGOMER K
HORSTEN M
WAMALA SP
MITTLEMAN MA
KIRKEEIDE R
SVANE B
RYDEN L
SCHENCKGUSTAFSSON K
Citation: K. Orthgomer et al., SOCIAL-RELATIONS AND EXTENT AND SEVERITY OF CORONARY-ARTERY DISEASE -THE STOCKHOLM-FEMALE-CORONARY-RISK-STUDY, European heart journal, 19(11), 1998, pp. 1648-1656
Authors:
OHLSSON A
NORDLANDER R
BENNETT T
BITKOVER C
KJELLSTROM B
LEE B
RYDEN L
Citation: A. Ohlsson et al., CONTINUOUS AMBULATORY HEMODYNAMIC MONITORING WITH AN IMPLANTABLE SYSTEM - THE FEASIBILITY OF A NEW TECHNIQUE, European heart journal, 19(1), 1998, pp. 174-184
Citation: M. Shimizu et al., ANGIOTENSIN-II TYPE-1 RECEPTOR BLOCKADE WITH CANDESARTAN PROTECTS THEPORCINE MYOCARDIUM FROM REPERFUSION-INDUCED INJURY, Journal of cardiovascular pharmacology, 32(2), 1998, pp. 231-238
Citation: K. Malmberg et al., EFFECT OF INTENSE INSULIN-TREATMENT ON HYPERGLYCEMIA IN DIABETIC-PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Diabetologia, 41, 1998, pp. 159-159
Citation: A. Norhammar et al., THE IMPORTANCE OF ADMISSION PLASMA-GLUCOSE IN NONDIABETIC PATIENTS WITH MYOCARDIAL-INFARCTION, Diabetologia, 41, 1998, pp. 1320-1320
Citation: L. Ryden et al., RISK MARKERS OF LONG-TERM OUTCOME IN PATIENTS WITH DIABETES AND ACUTEMYOCARDIAL-INFARCTION, Diabetologia, 41, 1998, pp. 1324-1324
Authors:
CLELAND JGF
MASSIE BM
PACKER M
ARMSTRONG PW
HOROWITZ JD
RYDEN L
POOLEWILSON PA
Citation: Jgf. Cleland et al., HEALTH ECONOMIC-BENEFITS OF TREATING PATIENTS WITH HEART-FAILURE WITHHIGH-DOSE LISINOPRIL VERSUS LOW-DOSE - THE ATLAS STUDY, Circulation, 98(17), 1998, pp. 698-698
Authors:
URETSKY BF
ARMSTRONG PW
CLELAND JG
HOROWITZ JD
MASSIE BM
RYDEN L
PACKER M
POOLEWILSON PA
Citation: Bf. Uretsky et al., ISCHEMIA AS A TRIGGER FOR SUDDEN-DEATH IN PATIENTS WITH CARDIOMYOPATHY AND HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE - RESULTS FROM THE ATLAS TRIAL, Circulation, 98(17), 1998, pp. 1031-1031
Authors:
QUINTANA M
LINDVALL K
BROLUND F
STORCK N
LINDBLAD LE
RYDEN L
Citation: M. Quintana et al., MARKERS OF RISK AFTER ACUTE MYOCARDIAL-INFARCTION - A COMPARISON OF CLINICAL-VARIABLES, AMBULATORY AND EXERCISE ELECTROCARDIOGRAPHY, ECHOCARDIOGRAPHY, AND STRESS ECHOCARDIOGRAPHY, Coronary artery disease, 8(6), 1997, pp. 327-334
Authors:
CONNELLY DT
STEINHAUS DM
KUBO SH
RYDEN L
NORDLANDER R
OHLSSON A
BENNETT T
STYLOS L
CARDINAL D
Citation: Dt. Connelly et al., EXPERIENCE WITH AN IMPLANTABLE HEMODYNAMIC MONITOR IN THE LONG-TERM ASSESSMENT OF CONGESTIVE-HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 84143-84143
Authors:
GRIP L
FRISON L
WALLENTIN L
DELLBORG M
GRANDE P
HALINEN M
HELD P
MYHRE E
RYDEN L
SWAHN E
SWEDBERG K
THYGESEN K
SLEIGHT P
WILHELMSEN L
NASLUND U
GUNDERSEN T
FISCHERHANSEN J
LEHTO S
BARRET M
NILSSON JE
TEGERNILSSON AC
THORSEN M
ANDERSEN F
LUNDSTROM M
HILDEBRAND A
DEFLONOLSSON C
FORSBY M
ISBERG P
LARSSON C
NORGAARD B
RASMUSSEN S
VIDEBAEK J
KLARLUND K
LANDORPH A
NIELSEN T
AGNER E
HOJGAARD MV
HELQVIST S
RASMUSSEN SL
EGSTRUP K
MYGIND L
HANSEN JF
SAJADIEH A
GILL S
HAGHFELT T
MARKENVARD J
THOMASSEN A
JENSEN N
PETERSEN J
JENSEN G
FISCHER T
SIPILA R
KIILAVUORI K
HAMALAINEN L
NURMINEN J
MELIN J
KOSKELA E
HURME H
VAUHONEN I
HONKANEN T
UTRIANEN S
HAMALAINEN T
LILJA M
UKKOLVA O
KIVELA H
SODERSTROM S
POHJOLASINTONEN S
HUSSI E
LARSEN A
FALANG JE
SCHARTUMHANSEN H
PAULSEN A
OMLAND T
HOLM T
EDVARDSEN T
THYBO NK
HAEREM J
KAPELRUD H
WAAGE K
ROSSEBO B
HAFSOY K
HAMMARSTROM E
ASTROM L
HALL E
WETTERVIK C
FORSBERG SA
TYGESEN H
FREDRIKSSON B
EKDAHL S
KIHLSTROM K
MAGNUSSON JO
STJERNA A
MARU F
NILSSON H
AKRAWI S
SAETRE H
AHLMARK G
AHLBERG G
LINDE B
HAGSTROM L
GUSTAFSSON G
GUSTAVSSON PE
LARSSON AC
ANDERSEN K
RUTER G
KIERKEGAARD A
HARDHAMMAR P
KARLSSON JE
SVENSSON O
LANDGREN F
HOLMBERG B
RYDEN S
WEINER L
DANIELEWICZ M
MALMROS B
NICOL P
JANZON M
OHLIN H
HANSEN O
TINGBERG E
NYMAN I
FJELSTAD B
AHLSTROM P
HEDBACK B
PERK J
SVENNBERG L
ELLSTROM J
BOMAN K
REMMETS J
KRISTENSSON BE
LINDER R
HULTING J
HOIJER J
MOLLER BH
LYCKSELL M
WAHLIN M
SANDSTEDT L
REDFORS A
BORRETZEN J
OSTBERG G
JOHANSSON B
MORNER S
LINDAHL B
OLDGREN J
JONSSON J
NEMECZE K
THORSEN S
JOHANSSON PA
SINNERSTAD B
LARSSON LE
BAND S
MARSELL R
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY, European heart journal, 18(9), 1997, pp. 1416-1425
Authors:
KAPPENBERGER L
LINDE C
DAUBERT C
MCKENNA W
MEISEL E
SADOUL N
CHOJNOWSKA L
GUIZE L
GRAS D
JEANRENAUD X
RYDEN L
GADLER F
AEBISCHER N
MABO P
SLADE A
ALIOT E
MALECKA L
LAVERGNE T
MAURER B
KULBERTUS H
MAHAUX V
SUTTON R
KRANICH W
Citation: L. Kappenberger et al., PACING IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY - A RANDOMIZED CROSSOVER STUDY, European heart journal, 18(8), 1997, pp. 1249-1256
Authors:
GADLER F
LINDE C
JUHLINDANNFELT A
RIBEIRO A
RYDEN L
Citation: F. Gadler et al., LONG-TERM EFFECTS OF DUAL-CHAMBER PACING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY WITHOUT OUTFLOW TRACT OBSTRUCTION AT REST, European heart journal, 18(4), 1997, pp. 636-642
Authors:
KAPPENBERGER LL
LINDE C
DAUBERT C
MCKENNA WJ
MEISEL E
SADOUL N
CHOJNOWSKA L
GUIZE L
GRAS D
JEANRENAUD X
RYDEN L
Citation: Ll. Kappenberger et al., ONE-YEAR FOLLOW-UP AFTER RANDOMIZED PACING ON OFF TREATMENT FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM)/, Circulation, 96(8), 1997, pp. 2585-2585